We advised WSE-listed Pure Biologics S.A. on a PLN 12 million financing transaction

26.06.2023 Case studies Capital Markets

tygrys

We advised WSE-listed Pure Biologics S.A. in a transaction to raise PLN 12 million in financing from a new investor, ACRX Investments Ltd.

The transaction was executed on the basis of an investment agreement and a loan agreement. The structure of the transaction envisaged that the Investor provided the Company with debt financing convertible into new issue shares of the Company and that the Company issued subscription warrants to the Investor.

Our advisory services were comprehensive and included the preparation and negotiation of transaction documentation, advice on the implementation of disclosure obligations, as well as the preparation of draft resolutions of the Company’s general meeting.

Pure Biologics is a biopharmaceutical company operating on the market since 2010. The Company’s activities focus on the discovery and development of biological drugs and the development of extracorporeal therapies. It operates in the areas of immuno-oncology, autoimmunity and neurological rare diseases, conducting research using proprietary technology platforms to select active molecules – antibodies and aptamers.

ACRX is a European transactional and distribution company in the TV rights market and is an investor in areas such as new technologies, web applications and biotechnology. ACRX is a major shareholder in one of the leading producers and publishers of computer games listed on the WSE.

Lawyers involved in the project

8. Krzysztof Marczuk 772x1158

Krzysztof Marczuk

Partner
Attorney-at-law

Capital Markets

Krzysztof Marczuk
12. Michal Wielinski 772x1158

Michał Wieliński

Managing Associate
Attorney-at-law

Capital Markets | Mergers and acquisitions (M&A) | Corporate law

Michał Wieliński
9. Magdalena Szeplik 772x1158

Magdalena Szeplik

Managing Associate
Advocate

Capital Markets | Corporate law

Magdalena Szeplik
18. Michal Dunikowski 1 772x1158

Michał Dunikowski

Associate
Tax Advisor

Capital Markets

Michał Dunikowski
Dawid Marciniak

Dawid Marciniak

Associate

Capital Markets | Corporate law

Dawid Marciniak

You may also like

21.05.2024

We advised Sescom S.A. and its major shareholders on a PLN 104 mln sale of a majority stake to Enterprise Investors

GESSEL is proud to have advised Sescom S.A. and its major shareholders on a PLN 104 mln sale of a majority stake to Enterprise Investors Sescom is a Warsaw-listed pro...

Case studies
We advised Sescom S.A. and its major shareholders on a PLN 104 mln sale of a majority stake to Enterprise Investors

29.04.2024

We advised Cavatina Holding S.A. on the establishment of their third bond issuance program

GESSEL continues to support Cavatina Holding S.A. in its bond issue programme, working on the 3rd bond issue (up to PLN 150 mln) and securing approval for the issue pros...

Case studies
We advised Cavatina Holding S.A. on the establishment of their third bond issuance program
Wszystkie case studies

Do you want to be up to date?

Subscribe to the newsletter!

tygrys